Skip to content

Virtual Reality Application in Chemotherapy Administration in Nurse Staff

Virtual Reality Application in Chemotherapy Administration in Nurse Staff

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04840732
Enrollment
90
Registered
2021-04-12
Start date
2018-03-01
Completion date
2019-02-28
Last updated
2021-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy Training

Keywords

3D virtual reality, administration

Brief summary

The present study wants to design a training program for chemotherapy with using VR among nurse staff. Then the investigators design a protocol to compare the training effects in the VR program and ISO document.

Detailed description

As technology advances, mobile devices have gradually turned into wearable devices. Furthermore, virtual reality (VR), augmented reality (AR), and mixed reality (MR) are being increasingly applied in medical fields such as medical education and training, surgical simulation, neurological rehabilitation, psychotherapy, and telemedicine. Research results demonstrate the ability of VR, AR, and MR to ameliorate the inconveniences that are often associated with traditional medical care, reduce incidents of medical malpractice caused by unskilled operations, and reduce the cost of medical education and training. What is more, the application of these technologies has enhanced the effectiveness of medical education and training, raised the level of diagnosis and treatment, improved the doctor-patient relationship, and boosted the efficiency of medical execution. The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in VR program and ISO document.

Interventions

Use VR software to make a training education program.

BEHAVIORALusual care

Chemotherapy training as usual care (for training chemotherapy skill).

Sponsors

Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigator and Outcomes Assessor blind

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* The staffs who require to implement chemotherapy skill in the hospital. Age over 20 years.

Exclusion criteria

* Refuse to join the study.

Design outcomes

Primary

MeasureTime frameDescription
Objective Structured Clinical Examination score (OSCE score)One monthOne month after intervention, we assess the OSCE score from participates, range from 0 to 100, higher score means better grade.

Secondary

MeasureTime frameDescription
Self-assessment skill scoreOne monthThe confidence of Self-assessment skill score after intervention. Range from 0 to 100, higher score means better grade.

Other

MeasureTime frameDescription
Knowledge and attitude (pre test)baseline dataChemotherapy knowledge and attitude, range 5-50, higer score means higher attitude to do chemotherapy

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026